Log In
BCIQ
Print this Print this
 

2401502

  Manage Alerts
Collapse Summary General Information
Company GlaxoSmithKline plc
DescriptionDomain antibody targeted multicomponent vaccine
Molecular Target
Mechanism of ActionVaccine
Therapeutic Modality 
Latest Stage of DevelopmentPhase I
Standard IndicationMelanoma
Indication DetailsTreat malignant melanoma
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today